SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ITRI LORETTTA M (Last) (First) (Middle) C/O GENTA INCORPORATED TWO CONNELL DRIVE (Street) BERKELEY HEIGHTS NJ 07922 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol GENTA INC DE/ [ GNTA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) President Pharmaceutical Dev.
	3. Date of Earliest Transaction (Month/Day/Year) 11/17/2003
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	11/17/2003		P		10,000	A	$9.68	26,995(1)	I	See Footnote(2)(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* ITRI LORETTTA M (Last) (First) (Middle) C/O GENTA INCORPORATED TWO CONNELL DRIVE (Street) BERKELEY HEIGHTS NJ 07922 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director 10% Owner X Officer (give title below) Other (specify below) President Pharmaceutical Dev.

1. Name and Address of Reporting Person* WARRELL RAYMOND P JR (Last) (First) (Middle) C/O GENTA INCORPORATED TWO CONNELL DRIVE (Street) BERKELEY HEIGHTS NJ 07922 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer

Explanation of Responses:

1. Includes 5,995 shares issued to Dr. Itri as a hiring bonus. Does not include 70,700 shares held by Reporting Person's spouse, of which 45,800 shares are held by the Reporting Person's spouse's individual retirement account, 9,900 shares held by the Reporting Person's children's custodial accounts (Reporting Person's spouse is custodian) and 10,000 shares that were issued to Relgen LLC, a privately held corporation, of which the Reporting Person's spouse is the majority stockholder.

2. Dr. Itri's individual retirement account holds 21,000 shares.

3. Dr. Warrell, a Section 16 Reporting Person, is the spouse of Dr. Itri. Dr. Warrell disclaims beneficial ownership of these and all of Dr. Itri's shares.

	Loretta M. Itri, M.D.	11/17/2003
	Raymond P. Warrell, Jr.	11/17/2003
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.